Drug intelligence / Profile preview

nano-ICG

Development stage
Preclinical
Modality
Nanoparticles → Drug Delivery Systems, Small Molecules
Administration
Intravenous, Intratumoral
01

Overview

Nano-ICG refers to nanoparticle formulations of indocyanine green (ICG), a near-infrared tricarbocyanine dye approved by the FDA for clinical use. Nanoformulation of ICG is designed to overcome limitations of free ICG, such as rapid degradation, short half-life, poor photostability, and lack of tumor specificity. By encapsulating or conjugating ICG within various nanocarriers—including polymers, liposomes, micelles, dendrimers, proteins (e.g., ferritin), inorganic materials (e.g., gold or magnetic nanoparticles), and hybrid systems—nano-ICG achieves enhanced stability in vivo and improved tumor targeting through passive accumulation or active targeting strategies. The primary mechanism involves fluorescence imaging for diagnostic purposes and photothermal/photodynamic therapy upon near-infrared irradiation; this enables both precise cancer imaging and targeted ablation of tumor cells via heat generation and reactive oxygen species production. Nano-ICG is under investigation primarily for cancer theranostics but also has potential applications in other fields such as cardiovascular disease diagnostics[3][5][6][7][8].

Other names
indocyanine green nanoparticlesICG-NPsICG-based nanocarrierICG-loaded nanoparticles

Beyond the preview

Go deeper on nano-ICG.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nano-ICG.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call